Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

3M Launches 3M M*Modal CDI Engage One For Healthcare Market

Published 09/16/2019, 11:02 PM
Updated 07/09/2023, 06:31 AM

3M Company’s (NYSE:MMM) business unit, 3M Health Information Systems, recently rolled out 3M M*Modal CDI Engage One — an advanced software for 3M 360 Encompass System users.

Developed with the help of advanced AI and natural language understanding technologies from 3M and its acquired M*Modal business (February 2019), the latest software provides clinical insight to clinical documentation improvement (CDI) experts, clinicians and coding teams on a real-time basis. Notably, the AI tools will provide physicians with precise and complete clinical story by streamlining document creation. This will help in improving patient care, quality outcomes and help organizations in achieving revenue integrity.

Developed on a single, cloud-based platform, CDI Engage One is compatible with the 3M 360 Encompass System, which has a large customer base in healthcare market. The combined use of CDI Engage One and 3M 360 Encompass will allow users to boost back-end CDI processes’ efficiency apart from saving hours of manual review for streamlined CDI queries, CDI worklist prioritization and clinical evidence-based documentation study.

Our Take

3M intends to become more competent on the back of product portfolio solidification. The company’s value model that comprises four priorities — Portfolio, Innovation, Transformation, and People and Culture — will help strengthen margins. In sync with its Portfolio priority, the company acquired the technology business of M*Modal — a prominent healthcare technology provider of conversational AI-powered systems. This buyout has been strengthening the company's Health Information Systems business. Notably, M*Modal assets generated revenues of $75 million in the second quarter of 2019.

However, rising cost of sales has been a major cause of concern for 3M over the last few quarters. On a year-over-year basis, the company's cost of sales escalated 1.7% and 2% in the first quarter and second quarter of 2019, respectively. Inflation in the prices of raw materials had primarily resulted in the increase.

3M currently carries a Zacks Rank #3 (Hold). In the past month, the company has returned 4.1%, almost on par with the industry’s growth of 4.3%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Stocks to Consider

Some better-ranked stocks from the same space are Federal Signal Corporation (NYSE:FSS) , Carlisle Companies Incorporated (NYSE:CSL) and Danaher Corporation (NYSE:DHR) . While Federal Signal and Danaher sport a Zacks Rank #1 (Strong Buy), Carlisle carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Federal Signal surpassed earnings estimates in each of the preceding four quarters, the average surprise being 16.48%.

Danaher outpaced earnings estimates in each of the preceding four quarters, the average surprise being 3.25%.

Carlisle outpaced earnings estimates thrice in the preceding four quarters, the average surprise being 17.16%.

5 Stocks Set to Double

Zacks experts released their picks to gain +100% or more in 2020. One is a famous cutting-edge food company that is “hiding in plain sight.” Swamped with competitors and ignored by Wall Street, its stock price floundered. Now, suddenly, it acquired a company that gives it an advantage none of its peers have.

Today, see all 5 stocks with extreme growth potential >>



Carlisle Companies Incorporated (CSL): Free Stock Analysis Report

Danaher Corporation (DHR): Free Stock Analysis Report

Federal Signal Corporation (FSS): Free Stock Analysis Report

3M Company (MMM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.